PRIMARY BILIARY CHOLANGITIS (PBC)
Clinical trials for PRIMARY BILIARY CHOLANGITIS (PBC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS (PBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PBC patients: experimental drug CS0159 enters Mid-Stage trial
Disease control OngoingThis study tests a new drug called CS0159 for people with primary biliary cholangitis (PBC), a chronic liver disease. About 75 adults who have not responded well to standard treatment will receive either CS0159 or a placebo for 12 weeks, followed by an open-label period. The goal…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New combo therapy could help Hard-to-Treat liver patients
Disease control ENROLLING_BY_INVITATIONThis study looks at whether adding the steroid prednisone to the standard medicine UDCA can help people with a liver disease called primary biliary cholangitis (PBC) who have a specific type of liver inflammation. About 244 adults will take part. The goal is to see if the combina…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated May 11, 2026 20:48 UTC